Please assess the completion status of the following clinical trial:

Trial Title: MUCOviscidose EXacerbation Outils Connectés Education Thérapeutique

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 12 years and over~* Cystic fibrosis confirmed by sweat test or genetic~* Able to understand and respect the protocol and its requirements~* Who signed the consent prior to any other procedure protocolFollowed in the same CF center during the study~* In clinically stable condition - no pulmonary exacerbation requiring intravenous antibiotics - in the previous 4 weeks)~* Prescribed at least one pulmonary medication (eg, inhaled mucolytic, inhaled or oral antibiotic therapy, hypertonic saline)~* Not undergone solid organ transplants~* With smartphone, computer or tablet connected to wifi access~Exclusion Criteria:~* Patient undergoing solid organ transplant~* Pregnancy or planned pregnancy during the period of the study~* Patient on exclusion period because of other clinical research esearch~* Patients who don't use connected devices during the 3 first months will be excluded from the study.

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Refusal Group (Type: OTHER): Refusal Questionnaires Intervention:~Clinic staff will email all patients or parents (pediatric settings) to introduce the study. A qualitative interview with 10 patients who declined to participate in the study will be conducted to identify the reason of refusal.
- Interventionnal Group (Type: OTHER): Connected Devices for 3 months (36 patients will be equipped with CDs-spirometer, oxymeter, scales, podometer watch and AURA device for sleep quality and analyze) Educationnal Intervention Connected Devices for 12 months Interviews

Based on this trial design, predict the completion outcome and termination type (if applicable).